Continuous readout versus titer-based assays of influenza vaccine trials: sensitivity, specificity, and false discovery rates

From MaRDI portal

(Redirected from Continuous readout versus titer-based assays of influenza vaccine trials: sensitivity, specificity, and false discovery rates)

Jump to:navigation, search

WARNING: Page is not linked to a MaRDI-Entity. Please add Sitelink / Wikibase-link.

Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Continuous_readout_versus_titer-based_assays_of_influenza_vaccine_trials:_sensitivity,_specificity,_and_false_discovery_rates&oldid=72289017"